Ext

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Acadia Pharmaceuticals Inc. of Class Action Lawsuit and Upcoming Deadline – ACAD

Retrieved on: 
Saturday, July 2, 2022 - 12:46am

NEW YORK, July 01, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Acadia Pharmaceuticals Inc. (Acadia or the Company)(NASDAQ: ACAD) and certain of its officers.

Key Points: 
  • NEW YORK, July 01, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Acadia Pharmaceuticals Inc. (Acadia or the Company)(NASDAQ: ACAD) and certain of its officers.
  • If you are a shareholder who purchased Acadia securities during the Class Period, you have until June 18, 2021 to ask the Court to appoint you as Lead Plaintiff for the class.
  • To discuss this action, contact Robert S. Willoughby at newaction@pomlaw.com or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions.

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Yext, Inc. of Class Action Lawsuit and Upcoming Deadline – YEXT

Retrieved on: 
Friday, July 1, 2022 - 4:45pm

NEW YORK, July 01, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Yext, Inc. (Yext or the Company) (NYSE: YEXT) and certain of its former officers.

Key Points: 
  • NEW YORK, July 01, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Yext, Inc. (Yext or the Company) (NYSE: YEXT) and certain of its former officers.
  • To discuss this action, contact Robert S. Willoughby at newaction@pomlaw.com or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext.
  • Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Spero Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline – SPRO

Retrieved on: 
Friday, July 1, 2022 - 4:42pm

To discuss this action, contact Robert S. Willoughby at newaction@pomlaw.com or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext.

Key Points: 
  • To discuss this action, contact Robert S. Willoughby at newaction@pomlaw.com or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext.
  • Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
  • On March 31, 2022, Spero issued a press release announcing the Companys fourth quarter and full year 2021 financial results.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Axsome Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline – AXSM

Retrieved on: 
Friday, July 1, 2022 - 4:20pm

To discuss this action, contact Robert S. Willoughby at newaction@pomlaw.com or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext.

Key Points: 
  • To discuss this action, contact Robert S. Willoughby at newaction@pomlaw.com or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext.
  • Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
  • Axsome is a biopharmaceutical company that engages in the development of novel therapies for central nervous system disorders in the United States.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Teladoc Health, Inc. of Class Action Lawsuit and Upcoming Deadline – TDOC

Retrieved on: 
Friday, July 1, 2022 - 4:14pm

NEW YORK, July 01, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Teladoc Health, Inc. (Teladoc or the Company) (NYSE: TDOC) and certain of its officers.

Key Points: 
  • NEW YORK, July 01, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Teladoc Health, Inc. (Teladoc or the Company) (NYSE: TDOC) and certain of its officers.
  • To discuss this action, contact Robert S. Willoughby at newaction@pomlaw.com or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext.
  • Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in IonQ, Inc. of Class Action Lawsuit and Upcoming Deadline – IONQ

Retrieved on: 
Friday, July 1, 2022 - 4:05pm

NEW YORK, July 01, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against IonQ, Inc. (IonQ or the Company) (NYSE: IONQ) and certain of its former officers.

Key Points: 
  • NEW YORK, July 01, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against IonQ, Inc. (IonQ or the Company) (NYSE: IONQ) and certain of its former officers.
  • Plaintiff pursues claims against the Defendants under the Securities Exchange Act of 1934 (the Exchange Act).
  • If you are a shareholder who purchased or otherwise acquired IonQ securities during the Class Period, you have until August 1, 2022 to ask the Court to appoint you as Lead Plaintiff for the class.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Tupperware Brands Corporation of Class Action Lawsuit and Upcoming Deadline – TUP

Retrieved on: 
Friday, July 1, 2022 - 3:58pm

NEW YORK, July 01, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Tupperware Brands Corporation (Tupperware or the Company) (NYSE: TUP) and certain of its officers.

Key Points: 
  • NEW YORK, July 01, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Tupperware Brands Corporation (Tupperware or the Company) (NYSE: TUP) and certain of its officers.
  • To discuss this action, contact Robert S. Willoughby at newaction@pomlaw.com or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext.
  • Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with on their Investment in Okta, Inc. of Class Action Lawsuit and Upcoming Deadline – OKTA

Retrieved on: 
Friday, July 1, 2022 - 3:57pm

NEW YORK, July 01, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Okta, Inc. (Okta or the Company) (NASDAQ: OKTA) and certain of its officers.

Key Points: 
  • NEW YORK, July 01, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Okta, Inc. (Okta or the Company) (NASDAQ: OKTA) and certain of its officers.
  • To discuss this action, contact Robert S. Willoughby at newaction@pomlaw.com or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext.
  • Okta provides identity solutions for enterprises, small and medium-sized businesses, universities, non-profits, and government agencies in the United States and internationally.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Enservco Corporation of Class Action Lawsuit and Upcoming Deadline – ENSV

Retrieved on: 
Friday, July 1, 2022 - 3:54pm

NEW YORK, July 01, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Enservco Corporation (Enservco or the Company) (NYSE: ENSV) and certain of its officers.

Key Points: 
  • NEW YORK, July 01, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Enservco Corporation (Enservco or the Company) (NYSE: ENSV) and certain of its officers.
  • To discuss this action, contact Robert S. Willoughby at newaction@pomlaw.com or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext.
  • Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Oscar Health, Inc. of Class Action Lawsuit and Upcoming Deadline – OSCR

Retrieved on: 
Friday, July 1, 2022 - 3:54pm

To discuss this action, contact Robert S. Willoughby at newaction@pomlaw.com or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext.

Key Points: 
  • To discuss this action, contact Robert S. Willoughby at newaction@pomlaw.com or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext.
  • Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
  • In the IPO, the Company sold 36,391,946 shares of Class A common stock at a price of $39.00 per share.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.